Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 5:15:1340230.
doi: 10.3389/fendo.2024.1340230. eCollection 2024.

Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women

Affiliations

Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women

Qiao-Song Han et al. Front Endocrinol (Lausanne). .

Abstract

Background: Several studies have compared the effects of fixed and flexible gonadotropin releasing hormone antagonist (GnRH-ant) protocols during in vitro fertilization and embryo transfer (IVF-ET). However, which GnRH-ant initiation strategy is better remains controversial. Moreover, no studies have assessed the optimal timing of GnRH-ant initiation in women of advanced maternal age (AMA).

Methods: In this retrospective cohort study, a total of 472 infertile women aged ≥ 35 years old undergoing their first IVF cycle from August 2015 to September 2021 at a tertiary academic medical center were recruited, of whom 136 followed fixed GnRH-ant protocol and 336 followed flexible GnRH-ant protocol. The primary outcomes measured were the cumulative live birth rate (CLBR) per IVF cycle and the time to live birth (TTLB) from the date of oocyte retrieval. Cox proportional models were used to calculate the hazard ratio (HR) and 95% confidence interval (CI) of CLBR regarding GnRH-ant timing.

Results: No significant difference in CLBR was found between the fixed and flexible GnRH-ant groups (27.9% vs 20.5%, p=0.105). The TTLB was also comparable between groups (10.56 vs 10.30 months, p=0.782). The Kaplan-Meier analysis for CLBR also showed comparable results between groups (P=0.351, HR=0.83; 95%CI: 0.56-1.23). After establishing a multiple Cox proportional hazard model, the fixed GnRH-ant group still had comparable CLBR with the flexible GnRH-ant group (HR=0.85; 95%CI: 0.53-1.38; P=0.518). Subgroup and sensitivity analyses also demonstrated similar results.

Conclusion: GnRH-ant protocols can be tailored to the needs of AMA women, and timing of GnRH-ant initiation can be adjusted flexibly.

Keywords: Cox proportional hazard model; advanced maternal age; cumulative live birth rate; fixed GnRH-ant protocol; flexible GnRH-ant protocol.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study. IVF, in vitro fertilization; ICSI, Intracytoplasmic sperm injection; IVF-D, in vitro fertilization with donor sperm.
Figure 2
Figure 2
Kaplan-Meier curves of the cumulative live birth rate (CLBR) in women who underwent fixed and flexible gonadotropin releasing hormone antagonist protocol. (A) CLBR of all the patients; (B) CLBR in women with fresh embryo transfer; (C) CLBR in women freezing all embryos.

Similar articles

Cited by

References

    1. Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. . GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update (2017) 23:560–79. doi: 10.1093/humupd/dmx017 - DOI - PubMed
    1. Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev (2016) 4:CD001750. doi: 10.1002/14651858.CD001750.pub4 - DOI - PMC - PubMed
    1. Al-Inany H, Aboulghar MA, Mansour RT, Serour GI. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol. Reprod BioMed Online (2005) 10:567–70. doi: 10.1016/s1472-6483(10)61661-6 - DOI - PubMed
    1. Filicori M, Cognigni GE, Pocognoli P, Ciampaglia W, Bernardi S. Current concepts and novel applications of LH activity in ovarian stimulation. Trends Endocrinol Metab TEM (2003) 14:267–73. doi: 10.1016/s1043-2760(03)00085-7 - DOI - PubMed
    1. Balasch J, Fábregues F. LH in the follicular phase: neither too high nor too low. Reprod BioMed Online (2006) 12:406–15. doi: 10.1016/s1472-6483(10)61991-8 - DOI - PubMed

Publication types

Substances